These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18178907)

  • 1. Might testosterone actually reduce mortality?
    Snyder PJ
    J Clin Endocrinol Metab; 2008 Jan; 93(1):32-3. PubMed ID: 18178907
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between serum testosterone and cardiovascular risk profile in the general population.
    Montagnana M; Lippi G
    Arch Intern Med; 2008 Jun; 168(12):1350. PubMed ID: 18574094
    [No Abstract]   [Full Text] [Related]  

  • 3. Low free testosterone predicts mortality from cardiovascular disease but not other causes: the Health in Men Study.
    Hyde Z; Norman PE; Flicker L; Hankey GJ; Almeida OP; McCaul KA; Chubb SA; Yeap BB
    J Clin Endocrinol Metab; 2012 Jan; 97(1):179-89. PubMed ID: 22013106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients.
    Kyriazis J; Tzanakis I; Stylianou K; Katsipi I; Moisiadis D; Papadaki A; Mavroeidi V; Kagia S; Karkavitsas N; Daphnis E
    Nephrol Dial Transplant; 2011 Sep; 26(9):2971-7. PubMed ID: 21427069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone levels and cardiovascular disease.
    Ma RC; Tong PC
    Heart; 2010 Nov; 96(22):1787-8. PubMed ID: 20959648
    [No Abstract]   [Full Text] [Related]  

  • 6. Testosterone making an entry into the cardiometabolic world.
    Basaria S; Dobs AS
    Circulation; 2007 Dec; 116(23):2658-61. PubMed ID: 18056536
    [No Abstract]   [Full Text] [Related]  

  • 7. Mendelian randomization suggests non-causal associations of testosterone with cardiometabolic risk factors and mortality.
    Haring R; Teumer A; Völker U; Dörr M; Nauck M; Biffar R; Völzke H; Baumeister SE; Wallaschofski H
    Andrology; 2013 Jan; 1(1):17-23. PubMed ID: 23258625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease.
    Carrero JJ; Qureshi AR; Nakashima A; Arver S; Parini P; Lindholm B; Bárány P; Heimbürger O; Stenvinkel P
    Nephrol Dial Transplant; 2011 Jan; 26(1):184-90. PubMed ID: 20624775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex steroids and mortality in men referred for coronary angiography.
    Wehr E; Pilz S; Boehm BO; März W; Grammer TB; Obermayer-Pietsch B
    Clin Endocrinol (Oxf); 2010 Nov; 73(5):613-21. PubMed ID: 20718764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone, hemostasis, and cardiovascular diseases in men.
    Brodin E; Vikan T; Hansen JB; Svartberg J
    Semin Thromb Hemost; 2011 Feb; 37(1):87-94. PubMed ID: 21249606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process.
    Jones TH; Saad F
    Atherosclerosis; 2009 Dec; 207(2):318-27. PubMed ID: 19464009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone and cardiovascular risk factors.
    Cohen PG
    Arch Intern Med; 2000 Jul; 160(13):2064-5. PubMed ID: 10888987
    [No Abstract]   [Full Text] [Related]  

  • 13. Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79.
    Haring R; Völzke H; Steveling A; Krebs A; Felix SB; Schöfl C; Dörr M; Nauck M; Wallaschofski H
    Eur Heart J; 2010 Jun; 31(12):1494-501. PubMed ID: 20164245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study.
    Agledahl I; Skjaerpe PA; Hansen JB; Svartberg J
    Nutr Metab Cardiovasc Dis; 2008 May; 18(4):256-62. PubMed ID: 17560771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of low serum testosterone levels to mortality in men.
    Berookhim BM
    Gend Med; 2012 Dec; 9(6):569-70. PubMed ID: 23148906
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of serum androgen concentrations with cardiovascular risk factors in elderly male patients with chronic systolic heart failure in China.
    Chen Q; Fu Z; Wu X; Jin L; Li J; Wang Y; Li X
    Aging Male; 2014 Sep; 17(3):155-60. PubMed ID: 24805790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related changes in plasma androgen levels and their association with cardiovascular risk factors in male Japanese office workers.
    Fukai S; Akishita M; Miyao M; Ishida K; Toba K; Ouchi Y
    Geriatr Gerontol Int; 2010 Jan; 10(1):32-9. PubMed ID: 20102380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Testosterone in old age: an up-date].
    Hilbert-Walter A; Büttner R; Sieber C; Bollheimer C
    Dtsch Med Wochenschr; 2012 Oct; 137(41):2117-22. PubMed ID: 23033170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma testosterone is associated with Framingham risk score.
    Chock B; Lin TC; Li CS; Swislocki A
    Aging Male; 2012 Sep; 15(3):134-9. PubMed ID: 22364636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden.
    Ohlsson C; Barrett-Connor E; Bhasin S; Orwoll E; Labrie F; Karlsson MK; Ljunggren O; Vandenput L; Mellström D; Tivesten A
    J Am Coll Cardiol; 2011 Oct; 58(16):1674-81. PubMed ID: 21982312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.